MedTrace Logo

Observational Study to Investigate the Effectiveness of Eprosartan on Pulse Pressure (Teveten_MS)

NCT02024100 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 109

Last updated 2025-01-27

No results posted yet for this study

Summary

The study is to identify the effectiveness of Eprosartan on pulse pressure in hypertensive patients with metabolic syndrome

-Definition of pulse pressure (PP): Difference between systolic and diastolic blood pressure produced one heart beat.

Conditions

Sponsors & Collaborators

  • Handok Inc.

    lead INDUSTRY

Principal Investigators

  • Chang Hwan Yoon, MD · Seoul National University Bundang Hospital

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-06
Primary Completion
2016-12-26
Completion
2016-12-26

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02024100 on ClinicalTrials.gov